News Corp. makes unsolicited offer for Dow Jones

Share this content:

Dow Jones & Co. yesterday said its board of directors had received an unsolicited proposal from News Corp. to acquire all of the outstanding shares of Dow Jones common stock and Class B common stock for $60 per share in cash, or in a combination of cash and News Corp. securities.

Dow Jones publishes The Wall Street Journal and other publications. Its New York Stock Exchange price saw a $20.95 jump yesterday - to $57.28 - after reports of the offer. Further increases were halted for news pending.

The Bancroft family is the majority shareholder for the company.

Dow Jones said that the board of directors and Bancroft family members, trustees and financial advisors were evaluating the proposal. The company made no assurance that a transaction would take place.

News Corp., a global media and entertainment giant, reported assets last year totaling about $59 billion. Its current media hold spans film, television, magazines, newspapers and book publishing. Some of its newspapers include Australia's Daily Telegraph, Britain's The Times and the United States' New York Post.

DMNotes is DMN's around-the-clock blog. Yes, a blog in 2016.

Bookmark this section and follow our RSS Feed here

Loading links....

Next Article in Media/Circulation

Sign up to our newsletters

Company of the Week

SK&A is a leading provider of U.S. healthcare information solutions and databases. As part of IMS Health, SK&A researches and maintains contact and profiling data for over 2 million healthcare providers, including 800,000+ prescribers. SK&A's data supports research and marketing initiatives for life sciences, medical device, managed healthcare, direct marketing, publishing, education and more. SK&A's proprietary databases are telephone-verified twice per year from its world class Research Centers. SK&A enables multi-channel marketing and sets the standard for data quality and reliability. SK&A's customers include many of America's most recognized healthcare, publishing and pharmaceutical institutions.

Featured Listings